Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor

[11] Lou N(2020)Nutrition interventions to treat low muscle mass in cancer J Cachexia Sarcopenia Muscle 11 366-80

[12] Choi MH(2017)Measurement of muscle mass in sarcopenia: from imaging to biochemical markers Aging Clin Exp Res 29 19-27

[13] Hopkins JJ(2008)Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 629-635

[14] Prado CM(2017)Prognostic value of computed tomography: measured parameters of body composition in primary operable gastrointestinal cancers Ann Surg Oncol 24 2241-2251

[15] Purcell SA(2017)prognostic significance of sarcopenia in patients with esophagogastric junction cancer or upper gastric cancer Ann Surg Oncol 24 1804-1810

[16] Laviano A(2020)Skeletal muscle loss after esophagectomy is an independent risk factor for patients with esophageal cancer Ann Surg Oncol 27 492-498

[17] Tosato M(2015)Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib J Cachexia Sarcopenia Muscle 6 343-350

[18] Prado CMM(2011)Nutritional screening and early treatment of malnutrition in cancer patients J Cachexia Sarcopenia Muscle 2 27-35

[19] Black D(2016)Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection Int J Surg 30 136-142

[20] Kudou K(2005)Lower serum albumin concentration and change in muscle mass: the health, aging and body composition study Am J Clin Nutr 82 531-537

[11] Lou N(2020)Nutrition interventions to treat low muscle mass in cancer J Cachexia Sarcopenia Muscle 11 366-80

[12] Choi MH(2017)Measurement of muscle mass in sarcopenia: from imaging to biochemical markers Aging Clin Exp Res 29 19-27

[13] Hopkins JJ(2008)Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 629-635

[14] Prado CM(2017)Prognostic value of computed tomography: measured parameters of body composition in primary operable gastrointestinal cancers Ann Surg Oncol 24 2241-2251

[15] Purcell SA(2017)prognostic significance of sarcopenia in patients with esophagogastric junction cancer or upper gastric cancer Ann Surg Oncol 24 1804-1810

[16] Laviano A(2020)Skeletal muscle loss after esophagectomy is an independent risk factor for patients with esophageal cancer Ann Surg Oncol 27 492-498

[17] Tosato M(2015)Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib J Cachexia Sarcopenia Muscle 6 343-350

[18] Prado CMM(2011)Nutritional screening and early treatment of malnutrition in cancer patients J Cachexia Sarcopenia Muscle 2 27-35

[19] Black D(2016)Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection Int J Surg 30 136-142

[20] Kudou K(2005)Lower serum albumin concentration and change in muscle mass: the health, aging and body composition study Am J Clin Nutr 82 531-537